May 10th, 2023

Li Auto Inc. (Nasdaq: LI) has released its Q1 earnings report, exceeding market expectations with an earnings per share (EPS) of $0.13. The consensus estimate had predicted an EPS of $0.01. This positive performance has garnered attention in the mark. Read more

May 10th, 2023

Rivian Automotive, Inc. (Nasdaq: RIVN) released its Q1 financial results, reporting an adjusted net loss of $1.43 per share. This result was slightly better than the consensus estimate of a loss of $1.59 per share. Despite the loss, there seems to be. Read more

May 10th, 2023

CTI BioPharma Corp. (Nasdaq: CTIC) has recently made headlines with the announcement of a significant development. The company has entered into a definitive agreement with Swedish Orphan Biovitrum AB, which will acquire CTI in an all-cash transaction. Read more

May 09th, 2023

Airbnb, Inc. (Nasdaq: ABNB) reported better-than-expected earnings for Q1, with an EPS of $0.18, compared to the consensus estimate of $0.09. However, this news did not sit well with investors, as ABNB's stock price saw a significant decrease of $14.. Read more

May 09th, 2023

In the latest round of Q1 earnings reports, Akamai Technologies, Inc. (Nasdaq: AKAM) beat consensus estimates with an adjusted EPS of $1.40, compared to the expected $1.32. This news was well-received by investors, as AKAM's stock price increased by . Read more

May 09th, 2023

Four companies have released their Q1 earnings reports, with three of them seeing positive movement in their after-hours trading prices. Hyliion Holdings Corp. (NYSE: HYLN) reported a Q1 loss of $0.16 per share, which was slightly better than the . Read more

May 09th, 2023

Harmonic Inc. (Nasdaq: HLIT) reported better than expected Q1 earnings, with adjusted earnings per share (EPS) of $0.12, beating the consensus estimate of $0.08. This news led to a surge in the company's stock price, which rose by 19.70% to $16.14 in. Read more

May 09th, 2023

Longeveron Inc. (Nasdaq: LGVN) released new long-term follow-up data from its ELPIS I trial, highlighting the potential survival benefit of Lomecel-B for patients with hypoplastic left heart syndrome (HLHS). HLHS is a rare and life-threatening congen. Read more

May 09th, 2023

Neuronetics, Inc. (Nasdaq: STIM) has reported a Q1 loss of $0.38 per share, which was slightly better than the consensus loss of $0.39 per share. As of this writing, $STIM is trading at $2.89, up by 31.36% or $0.69. Meanwhile, Voyager Therapeutics. Read more

May 09th, 2023

Novavax, Inc. (Nasdaq: NVAX) reported a Q1 loss of $3.41 per share, slightly better than the consensus loss of $3.46 per share.  In response to the challenging times, the company has announced cost-cutting measures to extend its cash runway a. Read more